ANPEP and cancer: The pharmacological inhibition of APN/CD13 forces CSCs into apoptosis [79] and makes cells more sensitive to the effects of chemotherapeutic drugs, e.g., 5-fluorouracil, doxorubicin, or TNFα [73,74,80], which is why APN/CD13 inhibitors are considered cancer chemosensitizers [81].